Permanent Atrial Fibrillation: Clinical Trials

10 trials for Permanent Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 recruiting. 4 Phase 4, 3 Not applicable, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4
Not applicable3Unknown 2, Recruiting 1
Phase 32Recruiting 1, Unknown 1
Phase 21Recruiting 1

Follow Permanent Atrial Fibrillation: new trials by email Literature Review of Permanent Atrial Fibrillation trials Research Report on Permanent Atrial Fibrillation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bundle Branch Pacing to Preserve Ejection Fraction in Atrial Fibrillation Trial
LBBA pacing, Conventional pacing - Permanent Atrial Fibrillation, Preserved Ejection Fraction
Not applicableRecruitingPoitiers University Hospital6422026-10-152026-10-19
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial
Dietary Caffeine Intake - Atrial Fibrillation (AF), Permanent Atrial Fibrillation
Phase 2 / Phase 3RecruitingHospital Universitario Getafe502026-07-272026-07-31
Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial
Accelerated pacing, Current standard of care - Atrial Fibrillation, Permanent Atrial Fibrillation
Not applicableUnknownMaastricht University Medical Center502024-05-012024-04-22
Clinical Efficacy of Left Bundle Branch Area Pacing for Patients With Permanent Atrial Fibrillation and Heart Failure
Left bundle branch area pacing, Biventricular pacing - Left Bundle Branch Area Pacing, Biventricular Pacing
Not applicableUnknownFu Wai Hospital, Beijing, China602022-07-182024-01-10
Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Bisoprolol, Digoxin - Permanent Atrial Fibrillation
Phase 4CompletedUniversity of Birmingham1612016-12-202021-06-18
Rate Control in Atrial Fibrillation II
Metoprolol, Diltiazem - Atrial Fibrillation, Permanent Atrial Fibrillation
Phase 4CompletedAsker & Baerum Hospital1222016-02-012022-01-05
Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
AV junction ablation, CRT, Optimized drug therapy - Permanent Atrial Fibrillation
Phase 3UnknownCentro Prevenzione Malattie Cardiovascolari N. e V. Corbella18302014-10-152021-01-20
Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Rivaroxaban, Fluindione, Warfarin - Permanent Atrial Fibrillation, Venous Thrombosis
Phase 4CompletedUniversity Hospital, Angers512013-05-212019-11-07
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
Permanent Atrial Fibrillation
CompletedBoston Scientific Corporation252013-04-012014-03-05
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study
Vitatron pacemaker C20 SSIR or T20 SSIR models - Permanent Atrial Fibrillation
Phase 4CompletedMedtronic BRC672006-01-012011-09-28

Narrower conditions

Atrial Fibrillation (6)  ·  Heart Failure (3)  ·  Arrhythmias, Cardiac (1)  ·  Heart Diseases (1)  ·  Pathologic Processes (1)  ·  Pulmonary Embolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Heart Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Arrhythmias, Cardiac (5)  ·  Pathologic Processes (5)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)

Interventions

Cardiac Resynchronization Therapy (2)  ·  Bisoprolol (1)  ·  Defibrillators, Implantable (1)  ·  Digoxin (1)  ·  Diltiazem (1)  ·  Metoprolol (1)  ·  Rivaroxaban (1)  ·  Warfarin (1)  ·  fluindione (1)

Sponsors

Asker & Baerum Hospital (1)  ·  Boston Scientific Corporation (1)  ·  Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella (1)  ·  Fu Wai Hospital, Beijing, China (1)  ·  Hospital Universitario Getafe (1)  ·  Maastricht University Medical Center (1)  ·  Medtronic BRC (1)  ·  Poitiers University Hospital (1)  ·  University Hospital, Angers (1)  ·  University of Birmingham (1)

Countries

France (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  China (1)  ·  Czechia (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Claudio Marsano, MD (1)  ·  Dipak Kotecha, MBChB PhD MRCP (1)  ·  Eraldo Occhetta, MD (1)  ·  Gianfranco Mazzocca, MD (1)  ·  Giorgio Corbucci, PhD (1)  ·  Jas Gill, MA MD FRCP FACC (1)  ·  Sara Reinvik Ulimoen, MD PhD (1)  ·  Xiaohan Fan, PhD (1)

Results publications

PMID 21606084, PMID 28729311, PMID 29858382, PMID 30165479, PMID 33351042, PMID 34453840, PMID 39009776, PMID 39819610, PMID 40087560, PMID 41462450

NIH funding

2015 (1)